| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |